Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Invest Ophthalmol Vis Sci ; 32(5): 1558-61, 1991 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-1849874

RESUMO

A mouse model for ocular reactivation of herpes simplex virus type 1 (HSV-1) was modified and used to study the effect of strain difference on the frequency of ocular HSV reactivation. Outbred male NIH white mice were immunized with 1.0 ml of anti-HSV serum with a neutralizing titer of 1:400 24 hr before infection and bilaterally infected at 10(5) plaque-forming units/eye with one of three HSV-1 strains: 17 Syn+, LAT+ (XC-20), or LAT- (X10-13). Latency-associated transcripts (LAT) are produced by strain 17 Syn+ and LAT+ but not by LAT-. The primary infection was monitored by ocular swabbing for HSV. Reactivation was induced by intravenous (i.v.) injection of cyclophosphamide (5 mg) followed 24 hr later by i.v. dexamethasone (0.2 mg). These drugs significantly reduced the white cell count between 0 and 6 days post-administration. The eyes were swabbed for 7 consecutive days to monitor reactivation, and HSV-1 reactivation was induced at the following frequencies in individual eyes: 17 Syn+ (32.5%), LAT+ (18.5%), and LAT- (2.5%) (P less than or equal to 0.002). Co-culture of trigeminal ganglia was done, and random isolates were checked to ascertain their identity. The HSV was recovered from individual trigeminal ganglia at the following frequencies: 17 Syn+ (83%), LAT+ (100%), and LAT- (67%) (P less than or equal to 0.091). These results confirm that the mouse can be used as a reactivation model for ocular HSV infection and that the presence of LAT facilitates reactivation in vivo in the mouse.


Assuntos
Genes Virais , Ceratite Dendrítica/microbiologia , Simplexvirus/genética , Ativação Viral , Animais , Anticorpos Antivirais/administração & dosagem , Córnea/microbiologia , Ciclofosfamida/administração & dosagem , Dexametasona/administração & dosagem , Modelos Animais de Doenças , Ceratite Dendrítica/imunologia , Masculino , Camundongos , Simplexvirus/crescimento & desenvolvimento , Simplexvirus/imunologia , Gânglio Trigeminal/microbiologia , Ativação Viral/efeitos dos fármacos
2.
Aviat Space Environ Med ; 71(11): 1137-41, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11086669

RESUMO

INTRODUCTION: Exercise rhabdomyolysis (ER) is a rare, sometimes catastrophic condition where muscle fibers breakdown in response to exertion and release their breakdown products into the circulation. While ER was brought to the medical community's attention largely through reports from military training establishments we are unaware of ER having resulted from the activities of military aircrew. This paper reports two cases of ER in military aircrew and discusses the condition and the approaches taken in determining their future aeromedical disposition. CASE REPORTS: Rhabdomyolysis occurred in two military pilots as a result of their aircrew duties. One, an experienced pilot, suffered rhabdomyolysis as a result of centrifuge based G-training, while the other, a cadet in training, suffered rhabdomyolysis precipitated by exertion during moderately warm weather. Further investigation revealed the second case to also have the Malignant Hyperthermia Trait. AEROMEDICAL DISPOSTION: After wide consultation and lengthy deliberations both of these aircrew were returned to their full previous flying status. No further complications or recurrences have occurred.


Assuntos
Medicina Aeroespacial , Avaliação da Deficiência , Exercício Físico , Hipertermia Maligna/diagnóstico , Hipertermia Maligna/etiologia , Militares , Rabdomiólise/diagnóstico , Rabdomiólise/etiologia , Adulto , Austrália , Canadá , Centrifugação/efeitos adversos , Humanos , Capacitação em Serviço , Masculino , Hipertermia Maligna/prevenção & controle , Educação Física e Treinamento , Rabdomiólise/sangue , Rabdomiólise/enzimologia , Rabdomiólise/prevenção & controle , Fatores de Risco
3.
J Trauma ; 47(5): 956-63, 1999 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-10568730

RESUMO

BACKGROUND: Hypertonic sodium acetate-dextran solution (HAD) causes vasodilatation and buffers metabolic acidosis. In controlled hemorrhage models, HAD in small volumes increases cardiac output without increasing blood pressure, thus creating a "high flow-low pressure" state. The objective of this study was to determine whether limited resuscitation of uncontrolled hemorrhage with HAD solution improves gut perfusion as measured by intestinal mucosal tonometry. METHODS: Three groups of 10 swine were bled 25 mL/kg by means of a femoral artery catheter to produce a mean blood pressure of 30 mm Hg. A 4-mm abdominal aortic laceration was then produced by pulling out a preimplanted wire loop. Groups were then randomly assigned to be resuscitated with either lactated Ringer's solution, a hypertonic saline-dextran solution or HAD solution sufficient to maintain a mean blood pressure of 45 mm Hg for 5 hours or until death. Outcomes were measured by survival, intraperitoneal blood loss, hemodynamic monitoring, and ileal mucosal tonometry. RESULTS: HAD infusions caused transient worsening of hypotension and were associated with increased mortality (p = 0.038). Blood loss and volumes required for resuscitation were significantly increased in the lactated Ringer's solution group. HAD showed significant buffering effect against metabolic acidosis in arterial blood only, but intestinal ileal mucosal tonometry was not different among the groups. CONCLUSION: HAD did not improve gut perfusion despite buffering the systemic acidosis of shock and caused increased mortality. Limited resuscitation with any of these solutions is associated with significant mucosal acidosis.


Assuntos
Aorta Abdominal/lesões , Volume Sanguíneo/efeitos dos fármacos , Hemodinâmica/efeitos dos fármacos , Soluções Isotônicas/farmacologia , Ressuscitação , Solução Salina Hipertônica/farmacologia , Choque Hemorrágico/terapia , Acetato de Sódio/farmacologia , Equilíbrio Ácido-Base/efeitos dos fármacos , Equilíbrio Ácido-Base/fisiologia , Animais , Volume Sanguíneo/fisiologia , Hemodinâmica/fisiologia , Soluções Hipertônicas , Mucosa Intestinal/fisiopatologia , Masculino , Lactato de Ringer , Choque Hemorrágico/fisiopatologia , Equilíbrio Hidroeletrolítico/efeitos dos fármacos , Equilíbrio Hidroeletrolítico/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA